Esoteric Testing Market by Type (Infectious Disease, Endocrinology, Oncology, Toxicology, Immunology, Neurology, Genetic Testing), Lab Type (Independent Labs, Hospital Laboratories), Technology (Mass Spectrometry, CLIA, ELISA, PCR) - Global Forecast to 2023
Click here for an in-depth analysis of the COVID-19 impact on the Esoteric Testing Market
Benchmarking the rapid strategy shifts of the Top 100 companies in the Esoteric Testing Market
Request Now[223 Pages Report] MarketsandMarkets forecasts the global esoteric testing market is projected to reach USD 35.24 billion by 2023 from USD 20.38 billion in 2018, at a CAGR of 11.6%. The rising demand for early and accurate disease diagnosis, increasing prevalence of infectious diseases, growing public-private investments as well as research funding & grants to develop innovative laboratory testing procedures, and advancements in clinical diagnostic techniques are the key factors driving the growth of the market. The objective of the report is to define, describe, and forecast the esoteric testing market size based on type, technology, laboratory type, and regions.
Helped a global management consulting services and solutions provider in delivering the market insights on esoteric testing services across Japan and Singapore.
Clients Problem Statement
Our client had initially approached us to help understand the esoteric testing services market in the South Korean region. After delivering the market size successfully and exceeding their expectations, our client then requested a deep dive study across the Japan and Singapore markets. They wished to understand the global size of the entire laboratory testing services market and wanted an in-depth analysis of this market by type, technology, and end user. 
MnM Approach
The MnM repository is referred to for high-level insights into the esoteric testing market. Each of the technologies, types, and end users involved in the esoteric testing services were analyzed through secondary research and validated with primary interviews. MnM also identified the key service providers in this market for the assigned countries and conducted interviews with the key industry experts to arrive at the market splits and shares. MnM triangulated all of this data to estimate the market size and forecast the growth of this market.
Revenue Impact (RI)
Helped a global management consulting services and solutions provider in delivering the market insights on esoteric testing services across Japan and Singapore.
By type, infectious diseases testing segment is expected to dominate the market during the forecast period
Among the type segment, the infectious diseases testing segment is expected to account for the largest share of the market during the forecast period. The large share of this segment is primarily attributed to the rising incidence/prevalence of target diseases (chronic, infectious, & lifestyle related diseases), the increasing adoption of advanced technologies, and the growing healthcare expenditure across the globe.
By technology, real-time PCR (qPCR) segment is expected to register the highest CAGR during the forecast period
The real-time PCR (qPCR) segment is expected to register the highest CAGR during the forecast period mainly due to factors such as growing geriatric population, rising incidence of infectious diseases and genetic disorders, increasing investments and availability of funds for PCR-based research, increasing preference for real-time PCR in prenatal genetic testing, and increasing use of biomarker profiling for disease diagnosis.
By laboratory type, independent & reference laboratories segment is projected to be the fastest growing during the forecast period
The independent & reference laboratories segment is expected to register the highest growth rate during the forecast period, owing to a large number of patient diagnosis undertaken for target diseases worldwide and competitive benefits offered by these providers over hospital-based laboratories.
North America accounted for the largest share of the Esoteric Testing market in 2017
North America to account for the largest market size during the forecast period.
North America is expected to account for the largest share of the market followed by Europe. However, Asia Pacific is expected to register the highest CAGR during the forecast period owing to rising penetration of cutting-edge clinical laboratory technologies among masses (especially in rural areas) in Asia Pacific countries, development in healthcare infrastructure, and significant rise in the disposable income in the region.
Market Dynamics
Driver: Growing awareness of personalized medicine
Growing patient awareness about the benefits of personalized medicine is one of the key factors resulting in the increased use of molecular diagnostics and genomics & proteomics technologies. Esoteric tests, which involve the analysis of 'rare' molecules or substances, are an essential part of individualized treatment regimens for many chronic diseases and conditions. These tests enable healthcare providers to make an informed clinical decision and reduce the likelihood of unnecessary adverse events. Some of the most widely used personalized treatment regimens include chemotherapy selection for breast cancer using gene expression profiles; therapeutic drug monitoring tests to select drugs for resistant HIV strains; and drugs selection based on the genetics and molecular profile of patients with autoimmune diseases.
Restraint: Unfavorable reimbursement scenario
Inadequate reimbursement, coupled with the dearth of qualified technical personnel to operate specialized esoteric tests, is a major factor restraining the growth of the esoteric testing market. Medicare revised its reimbursement mechanism for some esoteric tests, including molecular tests, in 2012. Some of these molecular pathology tests do not have their own Healthcare Common Procedure Coding System (HCPCS) codes and are instead billed using unlisted codes. In the case of these codes, Medicare Administrative Contractors (MACs) establish a payment amount for their local jurisdictions. According to CMS, approximately 75% of tests showed reimbursement rate reduction from January 2017. Some of these tests include molecular tests, targeted next-generation sequencing analysis panels of five to 50 genes, and cancer tests. These developments are expected to adversely affect the US molecular and genetic testing market, which will, in turn, hinder the growth of the esoteric testing market.
Opportunity: Growth opportunities in emerging countries
Developing economies such as India, China, South Korea, Brazil, Turkey, Russia, and South Africa are expected to offer potential growth opportunities for the major players operating in the esoteric testing services market. This can be attributed to the high disease prevalence, large patient population, improving healthcare infrastructure, and growing medical tourism in these countries.
The incidence of chronic diseases, such as cancer, has increased significantly in these countries. According to 2012 WHO estimates, annually, more than 60% of the total number of new cancer cases occur in Africa, Asia, and Central and South America. Moreover, the increasing competition in mature markets will further compel esoteric testing service providers to focus on emerging markets.
Challenge: Changing regulatory landscape
The esoteric testing industry is impacted by the frequently changing laws and regulations by regional governments. Regulations govern various clinical laboratory operations with the incorporation of various technical, operational, personnel, and quality requirements to ensure that the services provided by laboratories are accurate, reliable, and timely. There are repeated changes in these regulations, which creates complexities in the process of delivering esoteric testing services. For instance, the Centers for Medicare & Medicaid Services (CMS) regulates all laboratory testing performed on humans in the US through the Clinical Laboratory Improvement Amendments (CLIA), passed by Congress in 1988. In total, CLIA covers approximately 254,000 laboratory entities.
Scope of the Report
|
Report Metric |
Details |
|
Market size available for years |
20162023 |
|
Base year considered |
2017 |
|
Forecast period |
20162023 |
|
Forecast units |
Million (USD) |
|
Segments covered |
By type, technology, laboratory type, and region |
|
Geographies covered |
North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa |
|
Companies covered |
Labcorp (US), Quest Diagnostics (US), OPKO Health (US), Miraca holdings (Japan), Myriad Genetics (US), Sonic Healthcare (Australia), Primary Healthcare (Australia), Healthscope (Australia), Foundation Medicine (US), ACM Global Laboratories (US), Arup Laboratories (US), Fulgent Genetics (US), InVitae (US), Mayo Medical Laboratories (US), and Spectra Laboratories (US) |
The research report categorizes the Esoteric Testing market to forecast the revenues and analyze the trends in each of the following sub-segments:
Global Esoteric Testing Market, by Type
- Infectious Diseases Testing
- Endocrinology Testing
- Oncology testing
- Immunology Testing
- Genetic Testing
- Toxicology Testing
- Neurology Testing
- Others
Global Esoteric Testing Market, by Technology
- Chemiluminescence Immunoassay (CLIA)
- Enzyme-linked Immunosorbent Assay (ELISA)
- Mass Spectrometry
- Real Time - PCR
- Flow Cytometry
- Radioimmunoassay
- Others
Global Esoteric Testing Market, by Laboratory Type
- Independent & Reference Laboratories
- Hospital Laboratories
Global Esoteric Testing Market, by Region
- North America
- US
- Canada
- Europe
- Germany
- France
- Italy
- UK
- Spain
- RoE
- Asia Pacific
- Japan
- China
- India
- RoAPAC
- Latin America
- Brazil
- Mexico
- RoLA
- Middle East & Africa
Key Market Players
LabCorp (US), Quest Diagnostics (US), OPKO Health (US), Miraca Holdings (US), ARUP Laboratories (US), Myriad Genetics (US), Genomic Health (US), American Medical Laboratories (US), Foundation Medicines (US), Mayo Medical Laboratories (US), Primary Healthcare (Australia), Healthscope (Australia), Sonic Healthcare (UK), Fulgent Genetics (US), Spectra Laboratories (US), Nordic Lifesciences (US), InVitae (US), Unilabs (Switzerland), and SYNLAB (Germany).
Laboratory Corporation of America Holdings (US) is the leading player in the esoteric testing market. The company has a strong network of 39 laboratories and 1,700 patient service centers, and a network of branches and STAT laboratories across the US, Canada, and the UK. Through a combination of organic growth and disciplined acquisitions, LabCorp has continually expanded and diversified its business. Over the past three years, the company adopted acquisitions as its key growth strategy. For instance, in 2017, LabCorp (US) acquired Bode Technology (UK) and Pathology Associates Medical Laboratories (PAML) (US). In 2016, the company acquired Pathology (US) to expand its service offerings in the esoteric testing market. Inorganic growth strategies such as acquisitions and collaborations helped the company to sustain its leading position and enter high-growth markets.
Recent Developments
- In 2017, LabCorp launched ADAMTS13 test to distinguish diseases characterized by life-threatening, acute thrombotic microangiopathy (TMA), including most significantly thrombotic thrombocytopenia purpura (TTP).
- In 2017, Myriad Genetics, Inc. launched the EndoPredict test in the US for patients with ER+ HER2- early-stage breast cancer. This test launch will strengthen the companys oncology product portfolio and represents advancement in the treatment of patients with breast cancer.
- In 2017, Bristol-Myers Squibb Company and Foundation Medicine collaborated to leverage Foundation Medicine's comprehensive genomic profiling and molecular information solutions to identify predictive biomarkers such as Tumor Mutational Burden (TMB) and Microsatellite Instability (MSI) in patients.
- In 2017, LabCorp acquired Pathology Associates Medical Laboratories (PAML) based in the US. With the acquisition of PAML, LabCorp looking forward several joint ventures such as Colorado Laboratory Services (CLS), Kentucky Laboratory Services (KLS), MountainStar Clinical Laboratories (MSCL), PACLAB Network Laboratories (PACLAB) and Tri-Cities Laboratory (TCL). This acquisition will help the LabCorp to provide the outreach testing services and reference laboratory services to their patients, hospitals, clients, and clinicians.
- In 2017, GeneDx, a business unit of OPKO's BioReference Laboratories division, extended its partnership with the University of California Health (UC Health) for genetic, genomic, and molecular testing services.
Critical questions the report answers:
- Where will all these developments take the industry in the long term?
- What are the upcoming trends in the Esoteric Testing market?
- Which segment provides the most opportunity for growth?
- Who are the leading players operating in this market?
- What are the opportunities for new market entrants?
To speak to our analyst for a discussion on the above findings, click Speak to Analyst
Table of Contents
1 Introduction (Page No. - 16)
1.1 Objectives of the Study
1.2 Market Definition
1.3 Market Scope
1.3.1 Markets Covered
1.3.2 Regional Scope
1.4 Years Considered for the Study
1.5 Currency
1.6 Limitations
1.7 Stakeholders
2 Research Methodology (Page No. - 20)
2.1 Research Data
2.1.1 Secondary Data
2.1.1.1 Secondary Sources
2.1.2 Primary Data
2.1.2.1 Primary Sources
2.1.2.2 Key Industry Insights
2.1.2.3 Breakdown of Primaries
2.2 Market Size Estimation
2.2.1 Bottom-Up Approach
2.2.2 Top-Down Approach
2.3 Data Triangulation
2.4 Assumptions
3 Executive Summary (Page No. - 28)
4 Premium Insights (Page No. - 33)
4.1 Attractive Market Opportunities in the Esoteric Testing Market
4.2 Asia Pacific: Esoteric Testing Market, By Type
4.3 Esoteric Testing Market: Regional Growth Opportunities
4.4 Esoteric Testing Market: Regional Mix
4.5 Esoteric Testing Market: Developed Vs. Developing Countries
5 Market Overview (Page No. - 38)
5.1 Introduction
5.2 Market Dynamics
5.2.1 Drivers
5.2.1.1 Rising Geriatric Population and Subsequent Growth in the Prevalence of Chronic Diseases
5.2.1.2 Increasing Burden of Infectious Diseases
5.2.1.3 Rising Demand for Early Disease Detection Using Specialized Diagnostic Tests
5.2.1.4 Growing Awareness of Personalized Medicine
5.2.1.5 Increasing Funding and Research Grants for the Development of Innovative Esoteric Tests
5.2.2 Restraints
5.2.2.1 Unfavorable Reimbursement Scenario
5.2.3 Opportunities
5.2.3.1 Condition-Specific Markers and Tests With Advances in Genomics and Proteomics
5.2.3.2 Growth Opportunities in Emerging Countries
5.2.4 Challenges
5.2.4.1 Changing Regulatory Landscape
6 Industry Insights (Page No. - 46)
6.1 Introduction
6.2 Industry Trends
6.3 Regulatory Analysis
6.3.1 North America
6.3.1.1 US
6.3.1.2 Canada
6.3.2 Europe
6.3.3 Asia-Pacific
6.3.3.1 Japan
6.3.3.2 India
6.3.3.3 China
7 Esoteric Testing Market, By Type (Page No. - 51)
7.1 Introduction
7.2 Infectious Diseases Testing
7.3 Endocrinology Testing
7.4 Oncology Testing
7.5 Genetic Testing
7.6 Toxicology Testing
7.7 Immunology Testing
7.8 Neurology Testing
7.9 Others
8 Esoteric Testing Market, By Technology (Page No. - 76)
8.1 Introduction
8.2 Chemiluminescence Immunoassay
8.3 Enzyme-Linked Immunosorbent Assay
8.4 Mass Spectrometry
8.5 Real-Time Pcr
8.6 Flow Cytometry
8.7 Radioimmunoassay
8.8 Other Technologies
9 Global Esoteric Testing Market, By Laboratory Type (Page No. - 86)
9.1 Introduction
9.2 Independent & Reference Laboratories
9.3 Hospital Laboratories
10 Esoteric Testing Market, By Region (Page No. - 91)
10.1 Introduction
10.2 North America
10.2.1 US
10.2.2 Canada
10.3 Europe
10.3.1 Germany
10.3.2 France
10.3.3 UK
10.3.4 Italy
10.3.5 Spain
10.3.6 Rest of Europe
10.4 Asia Pacific
10.4.1 Japan
10.4.2 China
10.4.3 India
10.4.4 Australia
10.4.4 Rest of Asia Pacific
10.5 Latin America
10.5.1 Brazil
10.5.2 Mexico
10.5.3 Rest of Latin America
10.6 Middle East & Africa
11 Competitive Landscape (Page No. - 142)
11.1 Overview
11.2 Market Share Analysis, 2016
11.3 Competitive Leadership Mapping
11.3.1 Visionary Leaders
11.3.2 Innovators
11.3.3 Dynamic Differentiators
11.3.4 Emerging Companies
11.4 Competitive Scenario
11.4.1 Product Launches
11.4.2 Agreements, Partnerships, and Collaborations
11.4.3 Mergers and Acquisitions
11.4.4 Expansions
12 Company Profiles (Page No. - 154)
(Business Overview, Products Offered, Recent Developments, SWOT Anlysis, MnM View.)*
12.1 LabCorp
12.2 Quest Diagnostics
12.3 OPKO Health
12.4 Miraca Holdings
12.5 Myriad Genetics
12.6 Sonic Healthcare
12.7 Primary Health Care
12.8 Healthscope
12.9 Foundation Medicine
12.10 Acm Global Laboratories
12.11 ARUP Laboratories
12.12 Fulgent Genetics
12.13 Invitae
12.14 Mayo Medical Laboratories
12.15 Spectra Laboratories
12.16 Additional Companies
12.16.1 American Medical Laboratories
12.16.2 Genomic Health
12.16.3 American Esoteric Laboratories
12.16.4 Nordic Laboratories
12.16.5 Zeptometrix Corporation
*Business Overview, Products Offered, Recent Developments, SWOT Analysis, MnM View Might Not be Captured in Case of Unlisted Companies.
13 Appendix (Page No. - 212)
13.1 Insights of Industry Experts
13.2 Discussion Guide
13.3 Knowledge Store: Marketsandmarkets Subscription Portal
13.4 Introducing RT: Real-Time Market Intelligence
13.5 Available Customizations
13.6 Related Reports
13.7 Author Details
List of Tables (114 Tables)
Table 1 New Tests Launches By Key Players
Table 2 Esoteric Testing Market: Recent Acquisitions
Table 3 Esoteric Testing Market: Recent Collaborations and Agreements
Table 4 Stringency of Regulations for Clinical Laboratory Accreditation, By Country
Table 5 Accreditation Bodies in Europe
Table 6 Esoteric Testing Market, By Type, 20162023 (USD Million)
Table 7 Esoteric Tests for Infectious Diseases, By Key Market Player
Table 8 Infectious Diseases Esoteric Testing Market, By Country/Region, 20162023 (USD Million)
Table 9 Esoteric Tests for Endocrine Diseases, By Key Market Player
Table 10 Endocrinology Esoteric Testing Market, By Country/Region, 20162023 (USD Million)
Table 11 Esoteric Tests for Oncological Diseases, By Key Market Player
Table 12 Oncology Esoteric Testing Market, By Country/Region, 20162023 (USD Million)
Table 13 Esoteric Tests for Genetic Disorders, By Key Market Player
Table 14 Genetics Esoteric Testing Market, By Country/Region, 20162023 (USD Million)
Table 15 Esoteric Tests for Toxicology, By Key Market Player
Table 16 Toxicology Esoteric Testing Market, By Country/Region, 20162023 (USD Million)
Table 17 Esoteric Tests for Immunological Diseases, By Key Market Player
Table 18 Immunology Esoteric Testing Market, By Country/Region, 20162023 (USD Million)
Table 19 Esoteric Tests for Neurological Disorders, By Key Market Player
Table 20 Neurology Esoteric Testing Market, By Country/Region, 20162023 (USD Million)
Table 21 Other Esoteric Testing Market, By Country/Region, 20162023 (USD Million)
Table 22 Esoteric Testing Market, By Technology, 20162023 (USD Million)
Table 23 Chemiluminescence Immunoassay Market for Esoteric Testing, By Country/Region, 20162023 (USD Million)
Table 24 Enzyme-Linked Immunosorbent Assay Market for Esoteric Testing, By Country/Region, 20162023 (USD Million)
Table 25 Mass Spectrometry Market for Esoteric Testing, By Country/Region, 20162023 (USD Million)
Table 26 Real-Time PCR Market for Esoteric Testing, By Country/Region, 20162023 (USD Million)
Table 27 Flow Cytometry Market for Esoteric Testing, By Country/Region, 20162023 (USD Million)
Table 28 Radioimmunoassay Market for Esoteric Testing, By Country/Region, 20162023 (USD Million)
Table 29 Other Esoteric Technologies Market, By Country/Region, 20162023 (USD Million)
Table 30 Esoteric Testing Market, By Laboratory Type, 20162023 (USD Million)
Table 31 Esoteric Testing Market for Independent & Reference Laboratories, By Country/Region, 20162023 (USD Million)
Table 32 Esoteric Testing Market for Hospital Laboratories, By Country/Region, 20162023 (USD Million)
Table 33 Esoteric Testing Market, By Region, 20162023 (USD Million)
Table 34 North America: Esoteric Testing Market, By Country, 20162023 (USD Million)
Table 35 North America: Esoteric Testing Market, By Type, 20162023 (USD Million)
Table 36 North America: Esoteric Testing Market, By Technology, 20162023 (USD Million)
Table 37 North America: Esoteric Testing Market, By Laboratory Type, 20162023 (USD Million)
Table 38 U.S.: Infectious Disease Incidence, 2008-2012
Table 39 US: Key Macroindicators
Table 40 US: Esoteric Testing Market, By Type, 20162023 (USD Million)
Table 41 US: Esoteric Testing Market, By Technology, 20162023 (USD Million)
Table 42 US: Esoteric Testing Market, By Laboratory Type, 20162023 (USD Million)
Table 43 Canada: Key Macroindicators
Table 44 Canada: Esoteric Testing Market, By Type, 20162023 (USD Million)
Table 45 Canada: Esoteric Testing Market, By Technology, 20162023 (USD Million)
Table 46 Canada: Esoteric Testing Market, By Laboratory Type, 20162023 (USD Million)
Table 47 Europe: Esoteric Testing Market, By Country/Region, 20162023 (USD Million)
Table 48 Europe: Esoteric Testing Market, By Type, 20162023 (USD Million)
Table 49 Europe: Esoteric Testing Market, By Technology, 20162023 (USD Million)
Table 50 Europe: Esoteric Testing Market, By Laboratory Type, 20162023 (USD Million)
Table 51 Germany: Key Macroindicators
Table 52 Germany: Esoteric Testing Market, By Type, 20162023 (USD Million)
Table 53 Germany: Esoteric Testing Market, By Technology, 20162023 (USD Million)
Table 54 Germany: Esoteric Testing Market, By Laboratory Type, 20162023 (USD Million)
Table 55 France: Key Macroindicators
Table 56 France: Esoteric Testing Market, By Type, 20162023 (USD Million)
Table 57 France Esoteric Testing Market, By Technology, 20162023 (USD Million)
Table 58 France: Esoteric Testing Market, By Laboratory Type, 20162023 (USD Million)
Table 59 UK: Key Macroindicators
Table 60 UK: Esoteric Testing Market, By Type, 20162023 (USD Million)
Table 61 UK: Esoteric Testing Market, By Technology, 20162023 (USD Million)
Table 62 UK: Esoteric Testing Market, By Laboratory Type, 20162023 (USD Million)
Table 63 Italy: Key Macroindicators
Table 64 Italy: Esoteric Testing Market, By Type, 20162023 (USD Million)
Table 65 Italy: Esoteric Testing Market, By Technology, 20162023 (USD Million)
Table 66 Italy: Esoteric Testing Market, By Laboratory Type, 20162023 (USD Million)
Table 67 Spain: Key Macroindicators
Table 68 Spain: Esoteric Testing Market, By Type, 20162023 (USD Million)
Table 69 Spain: Esoteric Testing Market, By Technology, 20162023 (USD Million)
Table 70 Spain: Esoteric Testing Market, By Laboratory Type, 20162023 (USD Million)
Table 71 RoE: Esoteric Testing Market, By Type, 20162023 (USD Million)
Table 72 RoE: Esoteric Testing Market, By Technology, 20162023 (USD Million)
Table 73 RoE: Esoteric Testing Market, By Laboratory Type, 20162023 (USD Million)
Table 74 Asia Pacific: Esoteric Testing Market, By Country/Region, 20162023 (USD Million)
Table 75 Asia Pacific: Esoteric Testing Market, By Type, 20162023 (USD Million)
Table 76 Asia Pacific: Esoteric Testing Market, By Technology, 20162023 (USD Million)
Table 77 Asia Pacific: Esoteric Testing Market, By Laboratory Type, 20162023 (USD Million)
Table 78 Japan: Key Macroindicators
Table 79 Japan: Esoteric Testing Market, By Type, 20162023 (USD Million)
Table 80 Japan: Esoteric Testing Market, By Technology, 20162023 (USD Million)
Table 81 Japan: Esoteric Testing Market, By Laboratory Type, 20162023 (USD Million)
Table 82 China: Key Macroindicators
Table 83 China: Esoteric Testing Market, By Type, 20162023 (USD Million)
Table 84 China: Esoteric Testing Market, By Technology, 20162023 (USD Million)
Table 85 China: Esoteric Testing Market, By Laboratory Type, 20162023 (USD Million)
Table 86 India: Key Macroindicators
Table 87 India: Esoteric Testing Market, By Type, 20162023 (USD Million)
Table 88 India: Esoteric Testing Market, By Technology, 20162023 (USD Million)
Table 89 India: Esoteric Testing Market, By Laboratory Type, 20162023 (USD Million)
Table 90 Australia: Key Macroindicators
Table 91 Australia: Esoteric Testing Market, By Type, 20162023 (USD Million)
Table 92 Australia: Esoteric Testing Market, By Technology, 20162023 (USD Million)
Table 93 Australia: Esoteric Testing Market, By Laboratory Type, 20162023 (USD Million)
Table 94 RoAPAC: Esoteric Testing Market, By Type, 20162023 (USD Million)
Table 95 RoAPAC: Esoteric Testing Market, By Technology, 20162023 (USD Million)
Table 96 RoAPAC: Esoteric Testing Market, By Laboratory Type, 20162023 (USD Million)
Table 97 Rest of Latin America: Esoteric Testing Market, By Country/Region, 20162023 (USD Million)
Table 98 Latin America: Esoteric Testing Market, By Type, 20162023 (USD Million)
Table 99 Latin America: Esoteric Testing Market, By Technology, 20162023 (USD Million)
Table 100 Latin America: Esoteric Testing Market, By Laboratory Type, 20162023 (USD Million)
Table 101 Brazil: Key Macroindicators
Table 102 Brazil: Esoteric Testing Market, By Type, 20162023 (USD Million)
Table 103 Brazil: Esoteric Testing Market, By Technology, 20162023 (USD Million)
Table 104 Brazil: Esoteric Testing Market, By Laboratory Type, 20162023 (USD Million)
Table 105 Mexico: Key Macroindicators
Table 106 Mexico: Esoteric Testing Market, By Type, 20162023 (USD Million)
Table 107 Mexico: Esoteric Testing Market, By Technology, 20162023 (USD Million)
Table 108 Mexico: Esoteric Testing Market, By Laboratory Type, 20162023 (USD Million)
Table 109 Rest of Latin America: Esoteric Testing Market, By Type, 20162023 (USD Million)
Table 110 Rest of Latin America: Esoteric Testing Market, By Technology, 20162023 (USD Million)
Table 111 Rest of Latin America: Esoteric Testing Market, By Laboratory Type, 20162023 (USD Million)
Table 112 Middle East & Africa: Esoteric Testing Market, By Type, 20162023 (USD Million)
Table 113 Middle East & Africa: Esoteric Testing Market, By Technology, 20162023 (USD Million)
Table 114 Middle East & Africa: Esoteric Testing Market, By Laboratory Type, 20162023 (USD Million)
List of Figures (37 Figures)
Figure 1 Research Design
Figure 2 Data Triangulation Methodology
Figure 3 Infectious Disease Testing Segment to Dominate the Global Esoteric Testing Market, By Type, in 2018
Figure 4 Real-Time Pcr Segment to Register the Highest Growth Rate in the Esoteric Testing Market During the Forecast Period
Figure 5 Independent & Reference Laboratories to be the Fastest-Growing Segment in the Esoteric Testing Market Between 2018 & 2023
Figure 6 Asia Pacific to Witness the Highest Growth Rate in the Forecast Period
Figure 7 Increasing Prevalence of Chronic & Infectious DiseasesKey Factor Driving the Growth of the Esoteric Testing Market
Figure 8 Genetic Testing Segment to Register the Highest Growth Rate in the APAC Esoteric Testing Market During the Forecast Period
Figure 9 Emerging Countries to Register Highest CAGR During the Forecast Period
Figure 10 North America to Dominate the Esoteric Testing Market in the Forecast Period
Figure 11 Developing Countries to Register a Higher Growth Rate in the Forecast Period
Figure 12 Esoteric Testing Market: Drivers, Restraints, Opportunities, & Challenges
Figure 13 Increase in Geriatric Population, By Country 2011 Vs. 2015 Vs. 2030
Figure 14 Major Trend: Acquisitions Resulting in Market Consolidation
Figure 15 Esoteric Testing Market, By Type, 2018 Vs. 2023
Figure 16 Chemiluminescence Immunoassay Segment to Dominate the Esoteric Testing Market During the Forecast Period
Figure 17 Esoteric Testing Market, By Laboratory Type, 2018 Vs. 2023
Figure 18 Healthcare Expenditure Across Major Countries, 20002014
Figure 19 North America to Dominate the Esoteric Testing Market in 2023
Figure 20 Geographic Snapshot of the Global Esoteric Testing Market
Figure 21 North America: Esoteric Testing Market Snapshot
Figure 22 Europe: Esoteric Testing Market Snapshot
Figure 23 Asia Pacific: Esoteric Testing Market Snapshot
Figure 24 Players Majorly Adopted the Strategy of Product Launches Between January 2014 and March 2017
Figure 25 Global Esoteric Testing Market Share Analysis, By Key Player, 2016
Figure 26 LabCorp: Company Snapshot
Figure 27 Quest Diagnostics: Company Snapshot
Figure 28 OPKO Health: Company Snapshot
Figure 29 Miraca Holdings: Company Snapshot
Figure 30 Myriad Genetics: Company Snapshot
Figure 31 Sonic Healthcare: Company Snapshot
Figure 32 Primary Health Care: Company Snapshot
Figure 33 Healthscope: Company Snapshot
Figure 34 Foundation Medicine: Company Snapshot
Figure 35 Fulgent Genetics: Company Snapshot
Figure 36 Mayo Medical Laboratories: Company Snapshot
Figure 37 Fresenius Medical Care: Company Snapshot
- Triangulate with your Own Data
- Get Data as per your Format and Definition
- Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
- Any level of Personalization
- What are the Known and Unknown Adjacencies Impacting the Esoteric Testing Market
- What will your New Revenue Sources be?
- Who will be your Top Customer; what will make them switch?
- Defend your Market Share or Win Competitors
- Get a Scorecard for Target Partners
Growth opportunities and latent adjacency in Esoteric Testing Market